These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
240 related articles for article (PubMed ID: 30657565)
1. MiR-299-3p functions as a tumor suppressor in thyroid cancer by regulating SHOC2. Chen X; Qi M; Yang Q; Li JY Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):232-240. PubMed ID: 30657565 [TBL] [Abstract][Full Text] [Related]
2. MiR-548c-3p suppressed the progression of papillary thyroid carcinoma via inhibition of the HIF1α-mediated VEGF signaling pathway. Du Y; Zhu J; Chu BF; Yang YP; Zhang SL Eur Rev Med Pharmacol Sci; 2019 Aug; 23(15):6570-6578. PubMed ID: 31378898 [TBL] [Abstract][Full Text] [Related]
3. MiR-96-5p promotes the proliferation, invasion and metastasis of papillary thyroid carcinoma through down-regulating CCDC67. Liu ZM; Wu ZY; Li WH; Wang LQ; Wan JN; Zhong Y Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3421-3430. PubMed ID: 31081096 [TBL] [Abstract][Full Text] [Related]
4. MicroRNA-23a inhibits the growth of papillary thyroid carcinoma via regulating cyclin G1. Yin JJ; Cheng XY Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3431-3439. PubMed ID: 31081097 [TBL] [Abstract][Full Text] [Related]
5. Emerging roles of circUBAP2 targeting miR-370-3p in proliferation, apoptosis, and invasion of papillary thyroid cancer cells. Xiong H; Yu J; Jia G; Su Y; Zhang J; Xu Q; Sun X Hum Cell; 2021 Nov; 34(6):1866-1877. PubMed ID: 34346032 [TBL] [Abstract][Full Text] [Related]
6. Long non-coding RNA NR2F1-AS1 promoted proliferation and migration yet suppressed apoptosis of thyroid cancer cells through regulating miRNA-338-3p/CCND1 axis. Guo F; Fu Q; Wang Y; Sui G J Cell Mol Med; 2019 Sep; 23(9):5907-5919. PubMed ID: 31304680 [TBL] [Abstract][Full Text] [Related]
7. METTL3-Induced miR-222-3p Upregulation Inhibits STK4 and Promotes the Malignant Behaviors of Thyroid Carcinoma Cells. Lin S; Zhu Y; Ji C; Yu W; Zhang C; Tan L; Long M; Luo D; Peng X J Clin Endocrinol Metab; 2022 Jan; 107(2):474-490. PubMed ID: 34562008 [TBL] [Abstract][Full Text] [Related]
8. Circ-0003998 promotes cell proliferative ability and invasiveness by binding to miR-197-3p in osteosarcoma. Wang L; Du ZG; Huang H; Li FS; Li GS; Xu SN Eur Rev Med Pharmacol Sci; 2019 Dec; 23(24):10638-10646. PubMed ID: 31858530 [TBL] [Abstract][Full Text] [Related]
9. MiR-574-3p exerts as a tumor suppressor in ovarian cancer through inhibiting MMP3 expression. Zheng J; Zhou Y; Li XJ; Hu JM Eur Rev Med Pharmacol Sci; 2019 Aug; 23(16):6839-6848. PubMed ID: 31486483 [TBL] [Abstract][Full Text] [Related]
10. MicroRNA-3653-3p inhibited papillary thyroid carcinoma progression by regulating CRIPTO-1. Bai X; Xu Y; Liu Y Cell Mol Biol (Noisy-le-grand); 2023 Dec; 69(14):272-276. PubMed ID: 38279419 [TBL] [Abstract][Full Text] [Related]
11. Circulating Myeloid-derived Suppressor Cells Facilitate Invasion of Thyroid Cancer Cells by Repressing miR-486-3p. Chen L; Xiong L; Hong S; Li J; Huo Z; Li Y; Chen S; Zhang Q; Zhao R; Gingold JA; Zhu X; Lv W; Li Y; Yu S; Xiao H J Clin Endocrinol Metab; 2020 Aug; 105(8):. PubMed ID: 32492708 [TBL] [Abstract][Full Text] [Related]
12. Overexpression of long intergenic noncoding RNA LINC00312 inhibits the invasion and migration of thyroid cancer cells by down-regulating microRNA-197-3p. Liu K; Huang W; Yan DQ; Luo Q; Min X Biosci Rep; 2017 Aug; 37(4):. PubMed ID: 28539331 [TBL] [Abstract][Full Text] [Related]
13. Long non-coding RNA LINC00488 facilitates thyroid cancer cell progression through miR-376a-3p/PON2. Xie F; Li L; Luo Y; Chen R; Mei J Biosci Rep; 2021 Mar; 41(3):. PubMed ID: 33600548 [TBL] [Abstract][Full Text] [Related]
14. Downregulation of N-Acetylglucosaminyltransferase GCNT3 by miR-302b-3p Decreases Non-Small Cell Lung Cancer (NSCLC) Cell Proliferation, Migration and Invasion. Li Q; Ran P; Zhang X; Guo X; Yuan Y; Dong T; Zhu B; Zheng S; Xiao C Cell Physiol Biochem; 2018; 50(3):987-1004. PubMed ID: 30355927 [TBL] [Abstract][Full Text] [Related]
15. Downregulation of TSPAN13 by miR-369-3p inhibits cell proliferation in papillary thyroid cancer (PTC). Li P; Dong M; Wang Z Bosn J Basic Med Sci; 2019 May; 19(2):146-154. PubMed ID: 30114378 [TBL] [Abstract][Full Text] [Related]
16. MiR-152-3p promotes the development of chronic myeloid leukemia by inhibiting p27. Wang L; Wang Y; Lin J Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8789-8796. PubMed ID: 30575920 [TBL] [Abstract][Full Text] [Related]
17. MiR-150 Inhibits Cell Growth In Vitro and In Vivo by Restraining the RAB11A/WNT/β-Catenin Pathway in Thyroid Cancer. Bai D; Sun H; Wang X; Lou H; Zhang J; Wang X; Jiang L Med Sci Monit; 2017 Oct; 23():4885-4894. PubMed ID: 29023429 [TBL] [Abstract][Full Text] [Related]
18. MiR-548b-3p inhibits proliferation and migration of breast cancer cells by targeting MDM2. Sha MX; Huang XW; Yin Q Eur Rev Med Pharmacol Sci; 2020 Mar; 24(6):3105-3112. PubMed ID: 32271428 [TBL] [Abstract][Full Text] [Related]
19. Circ_0000144 facilitates the progression of thyroid cancer via the miR-217/AKT3 pathway. Fan YX; Shi HY; Hu YL; Jin XL J Gene Med; 2020 Dec; 22(12):e3269. PubMed ID: 32890417 [TBL] [Abstract][Full Text] [Related]
20. NLK, a novel target of miR-199a-3p, functions as a tumor suppressor in colorectal cancer. Han Y; Kuang Y; Xue X; Guo X; Li P; Wang X; Guo X; Yuan B; Zhi Q; Zhao H Biomed Pharmacother; 2014 Jun; 68(5):497-505. PubMed ID: 24972723 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]